E
Sernova Biotherapeutics Inc SVA.TO
TSX
Recommendation
Prev Close
$0.16
Volume
--
Avg Vol (90D)
116,309
Market Cap
$38.97M
Dividend & Yield
--
52-Week Range
$0.12 - $0.24
P/E (TTM)
--
EPS (TTM)
-$0.03
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Sinovac Biotech (SVA) Secures Nasdaq Listing Continuation
1/22/2026 - GuruFocus
Sinovac Biotech says Nasdaq hearings panel grants continued listing
1/22/2026 - TipRanks Financial Blog
Sinovac Biotech says Nasdaq hearings panel grants continued listing
1/22/2026 - The Fly
Sinovac Biotech says Nasdaq hearings panel grants continued listing
1/22/2026 - The Fly
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
1/22/2026 - Business Wire
Sinovac Biotech Updates Antigua Court Order On Board Composition
1/5/2026 - Nasdaq News: Markets
Sinovac Biotech (SVA) Faces Nasdaq Compliance Issues
1/4/2026 - GuruFocus
Sinovac Biotech receives Nasdaq notification regarding late filing of FY25
1/4/2026 - TipRanks Financial Blog
Sinovac Biotech receives Nasdaq notification regarding late filing of FY25
1/4/2026 - The Fly
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
1/4/2026 - Business Wire
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
1/4/2026 - Business Wire
Antigua High Court gives Sinovac Biotech board control until trial
12/17/2025 - The Fly
Sinovac:Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
12/17/2025 - Business Wire
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
11/18/2025 - Business Wire
Sinovac Biotech (SVA) Faces Shareholder Pressure Over Unpaid Dividend
11/11/2025 - GuruFocus
Sinovac Biotech shareholders express support for dividend
11/11/2025 - The Fly
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
11/11/2025 - CNW Group - News Releases
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
11/11/2025 - PR Newswire
Sinovac's New Clinical Trial: A Potential Game-Changer for Influenza Vaccination in Pregnant Women
10/27/2025 - TipRanks Financial Blog
Sinovac Biotech appoints UHY as independent auditor
10/24/2025 - TipRanks Financial Blog
Sinovac Biotech appoints UHY as independent auditor
10/24/2025 - The Fly
SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
7/11/2025 - Business Wire
Newly Elected Directors of Sinovac Hold the First Board Meeting
7/10/2025 - Business Wire
SINOVAC Biotech (SVA) Dismisses Unauthorized Meeting Claims SVA Stock News
7/9/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$10.51M
EBIT (TTM)
-$10.70M
Net Income (TTM)
-$11.21M
Balance Sheet
Total Assets (Q)
$545.30K
Total Debt (Q)
$3.41M
Total Liabilities (Q)
$18.44M
Book Value Per Share (Q)
-$0.0538
Cash Flow
Cash from Operations (TTM)
-$7.73M
Cash from Investing (TTM)
$18.00K
Cash from Financing (TTM)
$3.62M
Net Change in Cash (TTM)
-$4.09M
Filings
Filing Date
Friday, December 19, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
-0.34
7-Day Total Return
10.34%
30-Day Total Return
14.29%
60-Day Total Return
0.00%
90-Day Total Return
-11.11%
Year to Date Total Return
28.00%
1-Year Total Return
-21.95%
2-Year Total Return
-72.41%
3-Year Total Return
-86.89%
5-Year Total Return
-90.30%
52-week Low
Nov 24, 2025 - $0.12
52-week High
Feb 07, 2025 - $0.24
Valuation
Market Cap
$38.97M - Nano Cap
Enterprise Value
$42.23M
Price/Sales (TTM)
--
Price/Book (Q)
-2.97
Dividends and Shares
Shares Outstanding
328.71M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sernova.com
Phone Number
917-751-5713
Address
RPO Central Parkway
Mississauga, ON L5A 4H2
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid... more